Study reveals promising drug target for treating osteoporosis

Mechanisms governing the antagonistic bone-promoting and bone-resorbing effects of parathyroid hormone induction are unclear. New study by researchers from Tokyo University of Science reveals a novel PTH-inducible downstream target – Gprc5a that suppresses the proliferation and differentiation of bone-forming cells. Credit: Professor Tadayoshi Hayata from Tokyo University of Science Osteoporosis is a skeletal condition that leads to the weakening of bones, making them porous, fragile, and prone to breakage. A whopping 8.9 million fractures are caused by osteoporosis annually, with one fracture occurring every three seconds. The aging population is Read More

Related posts:

  1. New study reveals key protein that could help prevent excessive bone loss in osteoporosis
  2. New study demonstrates the efficacy of a promising celiac disease drug at the molecular level
  3. Mouse study suggests cancer drug could be used to target protein connection that spurs Parkinson’s disease
  4. Study reveals how an anesthesia drug induces unconsciousness
  5. Promising new target discovered in pancreatic cancer could boost chemotherapy and reduce spread
  6. Study reveals new mechanism of drug resistance in melanoma leptomeningeal disease
  7. Study reveals underuse of a key drug in patients with treatment-resistant schizophrenia
  8. Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use

Leave a Reply

Your email address will not be published. Required fields are marked *